Skip to main content

Advertisement

SpringerLink
Log in

n-3 Fatty acids and cardiovascular disease: the story is not over yet

  • Mini Review
  • Published:
Aging Clinical and Experimental Research Aims and scope Submit manuscript

Abstract

A large body of evidences suggest a beneficial role of n-3 poly-unsaturated fatty acids (n-3 PUFAs) on cardiovascular disease, but recent observations and meta-analyses have raised doubts on their real efficacy. Many of these analyses, however, should be interpreted with caution, because of methodological shortcomings, heterogeneity of population, variability of drug dose and composition and other interpretation issues, and are not able to convincingly confute the results of the major clinical trials. Indeed, they demonstrated the efficacy of n-3 PUFAs at least in particular subset of individuals, such as post-acute myocardial infarction patients, at high risk of ventricular arrhythmias. The utilization of n-3 poly-unsaturated fatty acids in the current clinical practice should not be withheld, yet.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kromhout D, Yasuda S, Geleijnse JM, Shimokawa H (2012) Fish oil and omega-3 fatty acids in cardiovascular disease: do they really work? Eur Heart J 33:436–443

    Article  CAS  PubMed  Google Scholar 

  2. ESC/EAS Guidelines for the Management of Dyslipidemia (2011) Eur Heart J 32:1769–1818

    Google Scholar 

  3. European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (2012) Eur Heart J 33:1635–1701

    Google Scholar 

  4. Mozaffarian D, Lemaitre RN, King IB, Song X, Huang H, Sacks FM, Rimm EB, Wang M, Siscovick DS (2013) Plasma phospholipid long-chain ω-3 fatty acids and total and cause-specific mortality in older adults: a cohort study. Ann Intern Med 158:515–525

    Article  PubMed  Google Scholar 

  5. Bang HO, Dyeberg J (1973) The composition of food consumed by Greenlandic Eskimos. Acta Med Scand 200:69–73

    Article  Google Scholar 

  6. Kroman N, Green A (1980) Epidemiologic studies in the Upernavick District, Greenland: incidence of some chronic disease 1950–1974. Acta Med Scand 208:401–406

    Article  Google Scholar 

  7. Daviglus ML, Stamler J, Orencia AJ, Dyer AR, Liu K, Greenland P et al (1997) Fish consumption and the 30-year risk of fatal myocardial infarction. N Engl J Med 336:1046–1053

    Article  CAS  PubMed  Google Scholar 

  8. Kromhout D, Bosschieter EB, de Lezenne Coulander C (1985) The inverse relationship between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 312:1205–1209

    Article  CAS  PubMed  Google Scholar 

  9. Rodriguez BL, Sharp DS, Abbott RD, Burchfiel CM, Masaki K, Chyou PH et al (1996) Fish intake may limit the increase in risk of coronary heart disease morbility and mortality among heavy smokers: The Honolulu Heart Programme. Circulation 94:952–956

    Article  CAS  PubMed  Google Scholar 

  10. Hu FB, Bronner L, Willett WC, Stampfer MJ, Rexrode KM, Albert CM et al (2002) Fish and omega-3 fatty acids intake and the risk of sudden death in women. JAMA 287:1815–1821

    Article  CAS  PubMed  Google Scholar 

  11. Marckmann P, Grønbaek M (1999) Fish consumption and coronary heart disease mortality: a systematic review of prospected cohort studies. Eur J Clin Nutr 53:585–590

    Article  CAS  PubMed  Google Scholar 

  12. Siscovick DS, Raghunathan TE, King I, Weinmann S, Wicklund KG, Albright J et al (1995) Dietary intake and cell membrane levels of long-chain omega-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA 274:1363–1367

    Article  CAS  PubMed  Google Scholar 

  13. Albert CM, Hennekens CH, O’Donnell CJ, Ajani UA, Carey VJ, Willett WC et al (1998) Fish consumption and risk of sudden cardiac death. JAMA 279:23–28

    Article  CAS  PubMed  Google Scholar 

  14. Albert CM, Campos H, Stampfer MJ, Ridker PM, Manson JE, Willett WC et al (2002) Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 346:1113–1118

    Article  CAS  PubMed  Google Scholar 

  15. Tavani A, Pelucchi C, Negri E, Bertuzzi M, La Vecchia C (2001) n-3 polyunsaturated fatty acids, fish, non fatal acute myocardial infarction. Circulation 104:2269–2272

    Article  CAS  PubMed  Google Scholar 

  16. Burr ML, Fehily AM, Gilbert JF, Rogers S, Holliday RM, Sweetnam PM et al (1989) Effect of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 30:757–761

    Article  Google Scholar 

  17. De Lorgeril M, Renaud S, Mamelle N, Salen P, Martin JL, Monjaud I, Guidollet J, Touboul P, Delaye J (1994) Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet 343:1454–1459

    Article  PubMed  Google Scholar 

  18. GISSI-Prevenzione Investigators (1999) Dietary supplement with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 354:447–455

    Article  Google Scholar 

  19. Marchioli R, Barzi F, Bomba E, Chieffo C, Di Gregorio D, Di Mascio R et al (2002) Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppoitaliano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione. Circulation 105:1897–1903

    Article  CAS  PubMed  Google Scholar 

  20. Billman GE, Hallaq H, Leaf A (1994) Prevention of ischemia-induced arrhythmias by n-3 fatty acids. Proc Natl Acad Sci USA 91:4427–4430

    Article  CAS  PubMed  Google Scholar 

  21. Kang JX, Leaf A (1994) Effects of long-chain polyunsaturated fatty acids on contraction of neonatal rat cardiac myocytes. Proc Natl Acad Sci USA 91:9886–9890

    Article  CAS  PubMed  Google Scholar 

  22. Leaf A, Kang JX, Xiao YF, Billman GE (2003) Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils. Circulation 107:2646–2652

    Article  PubMed  Google Scholar 

  23. Christensen JH, Skou HA, Fog L et al (2001) Marine n-3 fatty acids, wine intake, and heart variability in patients referred for coronary angiography. Circulation 103:651–657

    Article  CAS  PubMed  Google Scholar 

  24. Investigators GISSI-HF (2008) Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomized, double-blind, placebo-controlled trial. Lancet 372:1223–1230

    Article  Google Scholar 

  25. Yokoyama M, Origasa H, Matsuzaki M et al (2007) Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomized open-label, blinded endpoint analysis. Lancet 369:1090–1098

    Article  CAS  PubMed  Google Scholar 

  26. Bosch J, Gerstein HC, Dagenais GR, Diaz R et al (2012) n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. N Engl J Med 367:309–318

    Article  CAS  PubMed  Google Scholar 

  27. The Risk and Prevention Study Collaborative Group (2013) n-3 fatty acids in patients with multiple cardiovascular risk. New Engl J Med 368:1800–1808

    Article  Google Scholar 

  28. Rauch B, Schiele R, Scneider S, OMEGA Study Group et al (2010) OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction. Circulation 122:2152–2159

    Article  CAS  PubMed  Google Scholar 

  29. Kromhout D, Giltay EJ, Geleijnse JM (2010) n-3 Fatty acids and cardiovascular events after myocardial infarction. N Engl J Med 363:2015–2026

    Article  CAS  PubMed  Google Scholar 

  30. Dhein S, Michaelis B, Mohr FW (2005) Antiarrhythmic and electrophysiological effects of long-chain omega-3 polyunsaturated fatty acids. Naunyn Schmiedebergs Arch Pharmacol 371:202–211

    Article  CAS  PubMed  Google Scholar 

  31. Macchia A, Romero M, D’Ettorre A, Tognoni G, Mrini J (2013) Exploratory analysis on the use of statins with or without n-3 PUFA and major events in patients discharged for acute myocardial infarction: an observational retrospectivestudy. PLos One 8:e62772. doi:10.1371/journal.pone.0062772 Print2013

    Article  CAS  PubMed  Google Scholar 

  32. Chen Q, Cheng LQ, Xiao TH et al (2011) Effects of omega-3 fatty acid for sudden cardiac death prevention in patients with cardiovascular disease: a contemporary meta-analysis of randomized, controlled trials. Cardiovasc Drugs Ther 25:259–265

    Article  CAS  PubMed  Google Scholar 

  33. Filion KB, El Khoury F, Bielinski M et al (2010) Omega-3 fatty acids in high-risk cardiovascular patients: a meta-analysis of randomized controlled trials. BMC Cardiovasc Disord 10(24):1–11

    Google Scholar 

  34. Marik PE, Varon J (2009) Omega-3 dietary supplements and the risk of cardiovascular events: a systematic review. Clin Cardiol 32:365–372

    Article  PubMed  Google Scholar 

  35. Zhao YT, Chen Q, Sun YX et al (2009) Prevention of sudden death with omega-3 fatty acids in patients with coronary heart disease: a meta-analysis of randomized controlled trials. Ann Med 41:301–310

    Article  PubMed  Google Scholar 

  36. Kwak SM, Myung SK, Lee YJ et al (2012) Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease. Arch Intern Med 172:686–694

    Article  CAS  PubMed  Google Scholar 

  37. Delgado-Lista J, Perez-Martinez P, Lopez-Miranda J, Perez-Jimenez F (2012) Long chain omega-3 fatty acids and cardiovascular disease: a systematic review. Br J Nutr 107:S201–S213

    Article  CAS  PubMed  Google Scholar 

  38. Rizos EC, Ntzani EE, Bika E, Kostapanos MS, Elisaf MS (2012) Association between omega-3 fatty acids supplementation and risk of major cardiovascular disease events. A systematic review and metanalysis. JAMA 308:1024–1033

    Article  CAS  PubMed  Google Scholar 

  39. Galli C, Brenna JT (2013) Omega -3 fatty acid supplementation and cardiovascular disease events (letter). JAMA 309:27–29

    Article  Google Scholar 

  40. Vlachopoulos C, Richter D, Stefanidis C (2013) Omega-3 fatty acid supplementation and cardiovascular disease events (letter). JAMA 309:27–29

    Article  Google Scholar 

  41. Vlachopoulos C, Terentes-Printzios D, Richter D et al (2013) Omega-3 polyunsaturated fatty acid supplements dose and cardiovascular events: a systematic review and meta-analysis. JACC 61:E1421 (abst.)

    Article  Google Scholar 

Download references

Conflict of interest

The author states that there is no conflict of interest.

Author information

Authors and Affiliations

  1. Division of Cardiology, Department of Cardiac, Thoracic and Vascular Sciences, University Hospital, Via Giustiniani 2, 35128, Padua, Italy

    Claudio Bilato

Authors
  1. Claudio Bilato
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Claudio Bilato.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bilato, C. n-3 Fatty acids and cardiovascular disease: the story is not over yet. Aging Clin Exp Res 25, 357–363 (2013). https://doi.org/10.1007/s40520-013-0077-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40520-013-0077-y

Keywords

Search

Navigation